Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

As of 11th March 2015, a Phase II clinical trial of a potential Ebola treatment is underway in Sierra Leone. The trial of the therapy, TKM-Ebola-Guinea, is being led by Professor Peter Horby. TKM-Ebola-Guinea is a synthetic small interfering RNA therapeutic designed specifically to target the strain of the Ebola virus responsible for the present outbreak in Guinea, Liberia and Sierra Leone. Professor Horby said: "There are still around 10 new cases of Ebola being diagnosed every day in Sierra Leone. It’s therefore essential that we push.